ST
NKTR icon

Stifel Trust’s Nektar Therapeutics NKTR Stock Holding History

Stifel Trust’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$66K Hold
360
– – 0.01% 246
2014
Q2 		$70K Hold
360
– – 0.01% 240
2014
Q1 		$66K Sell
360
-192
-35% -$38K 0.01% 248
2013
Q4 		$94K Buy
552
+85
+18% +$13.7K 0.02% 215
2013
Q3 		$74K Hold
467
– – 0.01% 239
2013
Q2 		$81K Buy
+467
New +$71.6K 0.02% 222

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stifel Trust's NKTR Position: Q3 2014 in Review

Stifel Trust held its Nektar Therapeutics (NKTR) position steady in Q3 2014 at 360 shares worth $66K. The position accounts for 0.01% of the portfolio, ranked #246.

Stifel Trust first reported a position in NKTR in Q2 2013 and has held it in 6 quarters since. The position peaked at $94K in Q4 2013. 145 funds tracked by Wall St. Rank hold NKTR as of Q3 2014.

  • Stifel Trust held 360 shares of Nektar Therapeutics worth $66K as of Q3 2014.
  • Stifel Trust left its Nektar Therapeutics share count unchanged in Q3 2014.
  • Nektar Therapeutics made up 0.01% of Stifel Trust's portfolio in Q3 2014, its #246 holding.
  • Stifel Trust first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 6 quarters since.
  • Stifel Trust's Nektar Therapeutics position peaked at $94K in Q4 2013.
  • 145 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.